What's new? Log in Free sign up

VectivBio Holding (VECT)

Company Profile

Company profile

Ticker

VECT

Exchange

Website

Incorporated

Location

Fiscal year end

Industry (SIC)

Biological Products, (No Diagnostic Substances)

Biomotion Sciences Ordinary Shares • Amgen • Gilead Sciences • Biogen • Qiagen • Sterling Check • Bio-Techne • Moderna • Acorda Therapeutics • Saratoga Investment ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

VECT stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Securities registration termination

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Prospectus update (post-effective amendment)

Prospectus update (post-effective amendment)

Prospectus update (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Current report (foreign)

Transcripts

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

EVENTIDE ASSET MANAGEMENT, LLC

IRONWOOD PHARMACEUTICALS INC

Beryl Capital Management LLC

Novo Holdings A/S

ORBIMED ADVISORS LLC

ORBIMED ADVISORS LLC

Cormorant Asset Management, LP

EVENTIDE ASSET MANAGEMENT, LLC

CITADEL ADVISORS LLC

CHI Advisors LLC

Financial summary

Financial statements Chart VECT financial data

Quarter (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2023

VECT institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	52	14	+271.4%
Opened positions	44	3	+1366.7%
Closed positions	6	20	-70.0%
Increased positions	2	1	+100.0%
Reduced positions	3	4	-25.0%

13F shares	Current	Prev Q	Change
Total value	399.72 bn	53.07 bn	+653.2%
Total shares	103.75 mm	16.96 mm	+511.8%
Total puts	18.00 k	0.00	NEW
Total calls	26.60 k	0.00	NEW
Total put/call ratio	0.7	–	–

Largest owners	Shares	Value	Change
IRWD Ironwood Pharmaceuticals	61.30 mm	$1.04 bn	NEW
Orbimed Advisors	5.16 mm	$87.66 bn	NEW
Forbion Growth Opportunities Fund II Cooperatief U.A.	5.13 mm	$40.88 mm	0.0%
Beryl Capital Management	4.46 mm	$72.92 mm	NEW
TCG Crossover Management	3.11 mm	$52.93 bn	NEW
Bpifrance Participations	2.81 mm	$20.35 mm	0.0%
Versant Venture Capital V	2.79 mm	$0.00	0.0%
CHI Advisors	2.78 mm	$46.95 bn	-47.1%
Vivo Capital	2.33 mm	$39.36 bn	NEW
Glazer Capital	1.88 mm	$31.88 mm	NEW

Largest transactions	Shares	Bought/sold	Change
IRWD Ironwood Pharmaceuticals	61.30 mm	+61.30 mm	NEW
Orbimed Advisors	5.16 mm	+5.16 mm	NEW
Beryl Capital Management	4.46 mm	+4.46 mm	NEW
TCG Crossover Management	3.11 mm	+3.11 mm	NEW
CHI Advisors	2.78 mm	-2.47 mm	-47.1%
Vivo Capital	2.33 mm	+2.33 mm	NEW
Glazer Capital	1.88 mm	+1.88 mm	NEW
Ubs Oconnor	1.85 mm	+1.85 mm	NEW
Alpine Associates Management	1.81 mm	+1.81 mm	NEW
Arp Americas	1.21 mm	+1.21 mm	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.